Characterization of patients with diffuse acute otitis externa
Abstract
Introduction: diffuse acute otitis externa is an infectious process of the ear canal. It is characterized by earache that can worsen within a few hours and radiate to the temporomandibular and craniofacial regions. Auricular pain is intense, even if the area is gently manipulated.
Objective: to characterize patients with diffuse acute external otitis.
Methods: a cross-sectional descriptive observational study was carried out in 82 patients with diffuse acute external otitis, treated at the otorhinolaryngology service of the Provincial Hospital of Ciego de Ávila, from July 2016 to January 2017. Demographic variables (age, sex and place of origin) and microbiological variables (types of bacteria and antibiogram) were analyzed. Ethical precepts were met.
Results: patients from the urban area (62,20 %), from the group of 20 years and over (57,32 %), and males (52,44 %) predominated. The most identified germs were Staphylococcus aureus (39,02 %), and Pseudomonas aeruginosa (21,95 %). Chloramphenicol (34,15 %), ciprofloxacin (28,05 %) and gentamicin (25,61 %), in order of frequency, were the antibiotics with the greatest sensitivity to germs. Staphylococcus aureus responded better to chloramphenicol.
Conclusions: diffuse acute otitis externa was more frequent in men of urban origin, aged 20 years and over. Chloramphenicol was the most sensitive antibiotic. The most identified germ was Staphylococcus aureus; those affected by this showed a better response to antibiotic treatment. The therapeutic evidence provided by this study helps specialists make more effective decisions in clinical practice.Downloads
Published
How to Cite
Issue
Section
License
MediCiego does not apply publication charges. The journal is available in open access without restrictions, in compliance with the international policy on open access to information for the exchange of global knowledge.
The authors will retain their copyright and guarantee the journal the right of first publication of their work. MediCiego is licensed under the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES), so it is allowed to copy, reproduce, distribute, publicly communicate the work and generate derivative works, as long as the original author is cited and acknowledged. However, it is not allowed to use the original work for commercial or lucrative purposes.
Authors must sign a copyright agreement through an affidavit of authorship and originality, before publishing.
The authors authorize the publication of their writings; they retain the copyright, and assign to the journal all the rights protected by the Copyright Law that governs Cuba, and implies the edition to disseminate the work.
Likewise, they may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with the recognition of having been first published in this journal.
Declaration of authorship: download here the Affidavit
